Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content. Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

Merck To Move Ahead on a Heart Drug Where Pfizer Failed

(Wall Street Journal Health Blog) May 11, 2010 - It’s been nearly three and a half years since Pfizer abruptly pulled the plug on its $800 million effort to develop torcetrapib after the HDL-cholesterol raising drug was linked to a higher risk of death in a 15,000-patient study.

Skin Cancers Rising at an Alarming Rate

(The Seattle Times) May 11, 2010 - William James, president of the American Academy of Dermatology Association, said statistics show skin cancer now afflicts more Americans than all other cancers combined.

Exclusive: Obscure Biotech Regeneron on Verge of Big League

(Reuters) May 12, 2010 - Regeneron Pharmaceuticals Inc, a relatively unknown biotechnology company based in sleepy Tarrytown, New York, is not exactly a household name. But that is likely to change fast.

‘Good Morning America’s’ Sam Champion Gets Skin Cancer Surgery on Live TV

(ABCNews) May 12, 2010 - "Good Morning America" anchor Sam Champion this morning had surgery to remove skin cancer cells from his shoulder, undergoing the procedure on live television.

Diabetes Drug Trial Unethical and Dangerous, Researcher Charges

(Los Angeles Times Booster Shots) May 11, 2010 - The Canadian physician whose research escalated safety concerns about the Type 2 diabetes drug rosiglitazone (marketed as Avandia) is urging the U.S. Food and Drug Administrationto call a halt to a major international trial designed to compare the safety of Avandia against another diabetes drug in the same class.

Cancer: Trapping the Escape Artist

(Sanford-Burnham) May 11, 2010 - Researchers deliver a better understanding of anti-cell death proteins and a potential antagonist to defeat them.

FDA Plans Look At Genetic Test Set For Sale At Walgreens

(MorningStar) May 11, 2010 - The Food and Drug Administration plans to take a look at a new genetic test that Walgreen Co. plans to start selling at 6,000 of its stores this month.

Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial

(Yahoo! Finance) May 12, 2010 - Soligenix, Inc., a late-stage biopharmaceutical company, announced today that patient enrollment has been completed in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of orBec® for the prevention of acute Graft-versus-Host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning regimens.

Quest PharmaTech Announces Dosing Of First Patient In Its Prostate Cancer Clinical Trial

(FOX Business) May 11, 2010 - Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients.

Exploring Gender Differences in Colorectal Cancer Screenings

(ScienceBlog) May 11, 2010 - Among African Americans, colorectal cancer is the third most common cause of cancer-related death.